RWE4Decisions Symposium: Mobilising Real-World Data to Enhance HTA/Payer Decision-Making

On 20 November 2025, from 14:00 to 17:00 CET, RWE4Decisions will hold its annual Symposium online: “Mobilising Real-World Data to Enhance HTA/Payer Decision-Making“, moderated by Karen Facey and François Meyer (RWE4Decisions Facilitators). We will spotlight the evolving EU health data landscape, shaped by the implementation of the Health Technology Assessment (HTA) and European Health Data […]
Public Webinar: Transforming Real-World Evidence with AI: From Data to Decisions
Public Webinar: From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers
The 9 April RWE4Decisions Webinar “From Policy to Practice: EHDS Implementation to Support Better Real-World Evidence for HTA/Payers” brought together a vibrant community of over 200 participants to discuss how the European Health Data Space (EHDS) could generate robust real-world evidence (RWE) to support better informed, more timely HTA/Payers decisions. The discussion focused on practical […]
RWE4Decisions Symposium: Developing Real-World Evidence to Deliver Innovation in HTA
On 14 November, from 09:00 to 13:00 CET, RWE4Decisions held its annual hybrid Symposium in Brussels: “Developing Real-World Evidence to Deliver Innovation in HTA“, moderated by François Meyer (RWE4Decisions Facilitator) and Ashley Jaksa (Aetion). We explored how Real-World Evidence can drive innovation in Health Technology Assessment (HTA), focusing on the implications of the implementation of […]
Public Webinar: HTA/Payer Collaboration in the Nordics: The Role of Real-World Evidence
On the 23rd of October, between 15:00-16:30 CEST, RWE4Decisions hosted its last webinar for 2024: “HTA/Payer Collaboration in the Nordics – The Role of Real-World Evidence”. Speakers explored the creation and operation of the Joint Nordic HTA Bodies (JNHB) collaboration, how it evolved from FINOSE to JNHB, and how joint reports are taken up locally.
Public Webinar: Can Endpoints from Digital Technology Provide Meaningful Outcomes for HTA?
On 25 June 2024, RWE4Decisions hosted a webinar titled “Can endpoints from digital technology provide meaningful outcomes for Health Technology Assessment (HTA)?” At the webinar, speakers discussed how patient-generated health data could be analyzed to support Health Technology Assessment (HTA) bodies and Payers, delving into issues such as app governance models, the use of AI, […]
Stakeholder Actions to Generate Better Real-World Evidence for HTA and Payers
The 26th of March 2024 RWE4Decisions webinar discussed the revision of the 2020 paper “Real-world Evidence to Support Payer/HTA Decisions about Highly Innovative Technologies in the EU – Actions for Stakeholders”, available here. Together with the RWE4Decisions Learning Network, a new set of Actions for each stakeholder group has been drafted and presented at the webinar. […]
Real-World Evidence over the Medicine’s Lifecycle to Inform HTA/Payer Decisions
BIP Meeting Center (Room ‘Salles des Guichets’), Rue Royale 2-4, 1000 Bruxelles
RWE over the lifecycle of ATMPs to meet the HTA (Regulation) Needs
Join us on 10 October for the RWE4Decisions webinar on how RWE over the lifecycle of ATMPs could support the EU joint HTA work. You will hear from Prof Ana Hidalgo-Simon, who will set the scene on the clinical and regulatory context for ATMPs in the EU. A multi-stakeholder panel will then follow, representing the […]
Beating Cancer with Highly Innovative Technologies – What’s the role of RWE?
Join us on 18 April for the first webinar on using RWE to demonstrate the value of cancer treatments. A keynote address will outline the EU policy context in terms of the Beating Cancer Plan. A panel including policy, clinical, patient, industry and HTA experts will then discuss the opportunities and challenges of RWE generation […]